CellWell record HH-150982
Leptin/Adiponectin Ratio as a new multidimensional biomarker in obese patients with liver steatosis undergoing VLEKT: results from a pilot study
Francesco Balestra; Rossella Donghia; Maria De Luca; Dolores Stabile; Sergio Coletta; Giorgia Panzetta; Rita Palieri; Martina Di Chito; Giovanni De Pergola; Gianluigi Giannelli; Pasqua Letizia Pesole; Maria Principia Scavo
2026
In plain language
Very-low-energy ketogenic therapy reduced adipose tissue inflammation markers and liver steatosis, with the leptin-to-adiponectin ratio emerging as a multidimensional biomarker for metabolic remodeling.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-150982
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.